Global PET/CT Scanner Market Size By Type (Digital PET/CT, Analog PET/CT), By Application (Hospitals, Ambulatory Surgical Centres), By Region, And Segment Forecasts, 2023 to 2032

The Global PET/CT Scanner Market was valued at USD 2.3 billion in 2023 and is projected to reach USD 4.1 billion by 2031, growing at a CAGR of 7.4% during the forecast period from 2023 to 2031. The growth of this market is primarily driven by the rising incidence of chronic diseases such as cancer and cardiovascular disorders, increasing demand for hybrid imaging technologies, and the integration of artificial intelligence in medical imaging. PET/CT scanners play a pivotal role in early disease detection, treatment planning, and monitoring, particularly in oncology and neurology. The combination of anatomical and functional imaging in a single scan enhances diagnostic accuracy and clinical decision-making.

Drivers:

1. Rising Prevalence of Chronic Diseases:

An increasing number of cancer, cardiovascular, and neurological cases worldwide is driving the demand for PET/CT scanners. These systems enable precise tumor localization, staging, and therapy assessment, which are vital in managing such conditions.

2. Technological Advancements in Imaging Systems:

The development of next-generation PET/CT scanners with enhanced resolution, faster acquisition times, and reduced radiation exposure is contributing to greater adoption across healthcare facilities. The incorporation of time-of-flight (TOF) technology and digital detectors has significantly improved image quality.

3. Growing Use of AI and Image Fusion:

Artificial Intelligence (AI) integration in PET/CT imaging improves workflow efficiency, diagnostic precision, and patient outcomes. AI-based solutions assist in image reconstruction, anomaly detection, and report generation, making hybrid imaging more accessible.

Restraints:

1. High Equipment and Operational Costs:

PET/CT systems require substantial capital investment and ongoing maintenance, limiting adoption in low-resource healthcare settings. The cost barrier also includes radiopharmaceuticals and skilled personnel.

2. Limited Availability of Radiotracers:

Despite increasing demand, the short half-life of radiotracers and challenges in production and distribution hinder consistent and wide-scale availability, especially in remote and developing regions.

Opportunity:

1. Expanding Applications Beyond Oncology:

While widely used in oncology, PET/CT is gaining traction in cardiology, neurology, and infectious disease diagnostics. Emerging research supports its use in Alzheimer's disease and epilepsy, opening new growth avenues.

2. Growing Healthcare Infrastructure in Emerging Markets:

Countries in Asia-Pacific, Latin America, and the Middle East are investing in advanced diagnostic technologies, supported by rising healthcare budgets and awareness. This trend presents significant market expansion potential for PET/CT solutions.

Market by System Type Insights:

In 2023, the Fully Digital PET/CT Scanners segment dominated the market, accounting for the highest revenue share. These systems offer superior sensitivity, spatial resolution, and faster scanning capabilities. They are increasingly preferred in advanced diagnostic centers and research institutions. The Analog PET/CT Scanners segment still holds relevance in cost-sensitive markets but is expected to decline gradually with growing digital adoption.

Market by End-Use Insights:

The Hospitals & Diagnostic Imaging Centers segment emerged as the largest end-user in 2023, holding over 60% of the market share. These facilities frequently use PET/CT for comprehensive patient diagnostics and treatment planning. Research Institutes are projected to experience the fastest growth, driven by clinical trials and academic interest in hybrid imaging for new disease pathways.

Market by Regional Insights:

North America held the largest share of the global PET/CT scanner market in 2023, attributed to advanced healthcare infrastructure, strong presence of key manufacturers, and high adoption of cutting-edge imaging technologies. Asia-Pacific is expected to witness the fastest growth during the forecast period, fueled by increased investments in healthcare modernization, rising cancer prevalence, and government initiatives to improve early disease detection.

Competitive Scenario:

Key players in the global PET/CT scanner market include GE HealthCare, Siemens Healthineers, Canon Medical Systems, Philips Healthcare, United Imaging Healthcare, Hitachi Ltd., Neusoft Medical Systems, and Bruker Corporation. These companies focus on R&D investments, AI integration, strategic collaborations, and expansion in emerging markets.

Key Market Developments:

2023: GE HealthCare launched its next-generation digital PET/CT system with AI-based motion correction capabilities for improved image clarity.

2024: Siemens Healthineers partnered with a major U.S. cancer center to implement AI-integrated PET/CT solutions for personalized oncology care.

2025: United Imaging expanded its product reach in Latin America with cost-effective PET/CT systems targeting underserved regions.

Scope of Work – Global PET/CT Scanner Market

Report Metric Details

Market Size (2023) USD 2.3 billion

Projected Market Size (2031) USD 4.1 billion

CAGR (2023–2031) 7.4%

Market Segments By System Type, By End-Use, By Region

Growth Drivers Rising chronic disease prevalence, AI in imaging, hybrid imaging demand

Opportunities Emerging markets, non-oncology PET/CT applications

FAQs:

What is the current market size of the Global PET/CT Scanner Market?

The market was valued at USD 2.3 billion in 2023.

What is the major growth driver of the Global PET/CT Scanner Market?

The rising prevalence of chronic diseases and technological advancements in imaging systems.

Which is the largest region during the forecast period in the Global PET/CT Scanner Market?

North America leads the market due to its robust diagnostic infrastructure.

Which segment accounted for the largest market share in the Global PET/CT Scanner Market?

The Fully Digital PET/CT Scanner segment accounted for the largest share in 2023.

Who are the key market players in the Global PET/CT Scanner Market?

GE HealthCare, Siemens Healthineers, Canon Medical Systems, and Philips Healthcare are among the leading players.